Milton C. Ault III - Apr 19, 2024 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
Director, 10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Apr 19, 2024
Transactions value $
$688
Form type
4
Date filed
4/23/2024, 08:00 PM
Previous filing
Apr 18, 2024
Next filing
Apr 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $688 +1K +0.13% $0.69 772K Apr 19, 2024 By Ault Lending, LLC F1, F2
holding ALZN Common Stock 167K Apr 19, 2024 Direct
holding ALZN Common Stock 996K Apr 19, 2024 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 5.5K Apr 19, 2024 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.6882. The range of purchase prices on the transaction date was $0.6819 to $0.6895 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.